Assessment of subclinical vascular disease associated with ankylosing spondylitis

scientific article published on 15 January 2011

Assessment of subclinical vascular disease associated with ankylosing spondylitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3899/JRHEUM.100668
P698PubMed publication ID21239756

P50authorGyula SzegediQ1295375
Yehuda ShoenfeldQ1515807
P2093author name stringPál Soltész
Zoltán Szekanecz
György Paragh
György Kerekes
Sándor Sipka
Ildikó Seres
János Kappelmayer
Sándor Szántó
Nóra Bodnár
Zsuzsanna Gyurcsik Némethné
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectankylosing spondylitisQ52849
vascular diseaseQ1266890
P304page(s)723-729
P577publication date2011-01-15
P1433published inThe Journal of RheumatologyQ7743623
P1476titleAssessment of subclinical vascular disease associated with ankylosing spondylitis
P478volume38

Reverse relations

cites work (P2860)
Q88651282Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance
Q90479817Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
Q89417229Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study
Q50355546Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases.
Q38025994Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights
Q64079453Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis
Q38936667Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis.
Q89444267Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls
Q34072179Endothelial dysfunction in chronic inflammatory diseases
Q64082696Endothelial dysfunction in patients with ankylosing spondylitis
Q87476515Epicardial adipose tissue thickness in patients with ankylosing spondylitis
Q48007635Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease
Q64111747Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis
Q88936686Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk
Q34731291Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study.
Q35142805Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.
Q36727576Is there a relationship between endothelial nitric oxide synthase gene polymorphisms and ankylosing spondylitis?
Q55031386Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease?
Q27694518Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations
Q58765329Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment
Q38911778Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis
Q55263498Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities.
Q34979110Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study
Q40065441Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Q35993667Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study
Q89314644Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
Q38519523Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Q34164481Validated methods for assessment of subclinical atherosclerosis in rheumatology
Q55352845Whole-Body Cryotherapy Decreases the Levels of Inflammatory, Oxidative Stress, and Atherosclerosis Plaque Markers in Male Patients with Active-Phase Ankylosing Spondylitis in the Absence of Classical Cardiovascular Risk Factors.

Search more.